We asked 19 biotech leaders what breaks their deals. It wasn’t the science.Dylan Kissane12d agoThe CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering. The post We asked 19 biotech leaders what breaks their deals. It wasn’t the science. appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author …biotech
Biotech Seeks Turnaround as Investors Focus on Fundamentals6/23/2025Ernst & Young’s latest report shows biotech investors remain cautious in 2025, but innovation and partnerships offer path for a rebound.biotecheconomicsinvestment
Best or Worst of Times for U.S. Healthcare? Analysts Split on Outlook5/29/2025New reports from Jefferies and J.P. Morgan offer a split-screen view of biotech’s rough start and its potential recovery in the second half of 2025.biotecheconomicshealthcaremedicine
